Yusuke Takeshima
Overview
Explore the profile of Yusuke Takeshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seto T, Yukata K, Tsuji S, Takeshima Y, Honda T, Sakamoto A, et al.
Biochem Biophys Res Commun
. 2025 Jan;
747():151312.
PMID: 39799866
Impaired fracture healing in diabetic patients leads to prolonged morbidity and increased healthcare costs. Methylglyoxal (MG), a reactive metabolite elevated in diabetes, is implicated in various complications, but its direct...
2.
Yasumizu Y, Takeuchi D, Morimoto R, Takeshima Y, Okuno T, Kinoshita M, et al.
Cell Genom
. 2024 Feb;
4(2):100473.
PMID: 38359792
CD4 T cells are key mediators of various autoimmune diseases; however, their role in disease progression remains unclear due to cellular heterogeneity. Here, we evaluated CD4 T cell subpopulations using...
3.
Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, et al.
Nat Genet
. 2023 Apr;
55(5):753-767.
PMID: 37095364
Mechanisms underpinning the dysfunctional immune response in severe acute respiratory syndrome coronavirus 2 infection are elusive. We analyzed single-cell transcriptomes and T and B cell receptors (BCR) of >895,000 peripheral...
4.
Yamada S, Nagafuchi Y, Wang M, Ota M, Hatano H, Takeshima Y, et al.
Ann Rheum Dis
. 2023 Mar;
82(6):809-819.
PMID: 36918189
Objectives: Little is known about the immunology underlying variable treatment response in rheumatoid arthritis (RA). We performed large-scale transcriptome analyses of peripheral blood immune cell subsets to identify immune cells...
5.
Sugimori Y, Iwasaki Y, Takeshima Y, Okubo M, Kobayashi S, Hatano H, et al.
ACR Open Rheumatol
. 2023 Jan;
5(2):93-102.
PMID: 36651871
Objective: Idiopathic inflammatory myopathies (IIM) demonstrate characteristic clinical phenotypes depending on the myositis-specific antibody (MSAs) present. We aimed to identify common or MSA-specific immunological pathways in different immune cell types...
6.
Yamaguchi Y, Kato Y, Edahiro R, Sondergaard J, Murakami T, Amiya S, et al.
JCI Insight
. 2022 Oct;
7(22).
PMID: 36282593
Consecutive mRNA vaccinations against SARS-CoV-2 reinforced both innate and adaptive immune responses. However, it remains unclear whether the enhanced innate immune responses are mediated by epigenetic regulation and, if so,...
7.
Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, et al.
Cell
. 2022 Aug;
185(18):3375-3389.e21.
PMID: 35998627
Systemic lupus erythematosus (SLE) is a complex autoimmune disease involving multiple immune cells. To elucidate SLE pathogenesis, it is essential to understand the dysregulated gene expression pattern linked to various...
8.
Okubo M, Sumitomo S, Tsuchida Y, Nagafuchi Y, Takeshima Y, Yanaoka H, et al.
Arthritis Res Ther
. 2022 Aug;
24(1):186.
PMID: 35941595
Background: Behçet's syndrome (BS) is an immune-mediated disease characterized by recurrent oral ulcers, genital ulcers, uveitis, and skin symptoms. HLA-B51, as well as other genetic polymorphisms, has been reported to...
9.
Yasumizu Y, Ohkura N, Murata H, Kinoshita M, Funaki S, Nojima S, et al.
Nat Commun
. 2022 Jul;
13(1):4230.
PMID: 35869073
Myasthenia gravis (MG) is a neurological disease caused by autoantibodies against neuromuscular-associated proteins. While MG frequently develops in thymoma patients, the etiologic factors for MG are not well understood. Here,...
10.
Iwasaki Y, Takeshima Y, Nakano M, Okubo M, Ota M, Suzuki A, et al.
Rheumatology (Oxford)
. 2022 Jun;
62(2):905-913.
PMID: 35689621
Objectives: To investigate metabolite alterations in the plasma of SLE patients to identify novel biomarkers and provide insight into SLE pathogenesis. Methods: Patients with SLE (n = 41, discovery cohort...